Toshinori Kamisako, Yuji Tanaka. Oltipraz ameliorates the progression of steatohepatitis in Nrf2-null mice fed a high-fat diet. Journal of clinical biochemistry and nutrition. 2022. 70. 2. 147-153
Yuji Tanaka, Toshinori Kamisako. Regulation of the expression of cholesterol transporters by lipid-lowering drugs ezetimibe and pemafibrate in rat liver and intestine. Biochimica et biophysica acta. Molecular basis of disease. 2021. 1867. 11. 166215-166215
Yuji Tanaka, Takanori Ikeda, Hiroshi Ogawa, Toshinori Kamisako. Ezetimibe markedly reduces hepatic triglycerides and cholesterol in rats fed on fish oil by increasing the expression of cholesterol efflux transporters. The Journal of pharmacology and experimental therapeutics. 2020
Yuji Tanaka, Takanori Ikeda, Kazuo Yamamoto, Hiroshi Ogawa, Toshinori Kamisako. Gender-divergent expression of lipid and bile acid metabolism related genes in adult mice offspring of dams fed a long-term high-fat diet before and during pregnancy and lactation. HEPATOLOGY. 2016. 64. 157A-158A
Yuji Tanaka, Toshinori Kamisako. Wasabi derivative 6-methylsulfinylhexyl isothiocyanate, a potent Nrf2 activator, prevents the fatty liver produced by a high-fat diet but did not attenuate hepatic iron overload in mice. HEPATOLOGY. 2013. 58. 554A-555A
Yuji Tanaka, Toshinori Kamisako. The Nrf2 activator oltipraz alters cholesterol and bile acid metabolism related genes expression via Nrf2-dependent and independent signaling in mice fed a high-fat diet. HEPATOLOGY. 2012. 56. 540A-541A
Adaptive regulation of bile acid and cholesterol transporters in mouse kidney and intestine during alpha-naphthylisothiocyanate (ANIT)-induced cholestasis
(The59th Annual Meeting of the Society of toxicology(SOT) 2020)
Ezetimibe markedly reduces hepatic triglycerides and cholesterol in fish oil-fed rats
(AASLD Annual Meeting 2019)